- Home
- HLP vs SRTS Comparison
HLP vs SRTS Comparison
Compare HLP & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- SRTS
- Stock Information
- Founded
- HLP 2021
- SRTS 2010
- Country
- HLP China
- SRTS United States
- Employees
- HLP N/A
- SRTS N/A
- Industry
- HLP Industrial Machinery/Components
- SRTS Medical/Dental Instruments
- Sector
- HLP Industrials
- SRTS Health Care
- Exchange
- HLP Nasdaq
- SRTS Nasdaq
- Market Cap
- HLP 52.1M
- SRTS 51.8M
- IPO Year
- HLP 2023
- SRTS 2016
- Fundamental
- Price
- HLP $1.28
- SRTS $3.14
- Analyst Decision
- HLP
- SRTS Strong Buy
- Analyst Count
- HLP 0
- SRTS 3
- Target Price
- HLP N/A
- SRTS $8.00
- AVG Volume (30 Days)
- HLP 126.5K
- SRTS 75.5K
- Earning Date
- HLP 09-19-2025
- SRTS 11-13-2025
- Dividend Yield
- HLP N/A
- SRTS N/A
- EPS Growth
- HLP N/A
- SRTS N/A
- EPS
- HLP N/A
- SRTS N/A
- Revenue
- HLP $14,105,620.00
- SRTS $37,564,000.00
- Revenue This Year
- HLP N/A
- SRTS N/A
- Revenue Next Year
- HLP N/A
- SRTS $46.14
- P/E Ratio
- HLP N/A
- SRTS N/A
- Revenue Growth
- HLP N/A
- SRTS 3.29
- 52 Week Low
- HLP $0.61
- SRTS $3.03
- 52 Week High
- HLP $1.87
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- HLP 82.28
- SRTS 38.96
- Support Level
- HLP $0.95
- SRTS $3.06
- Resistance Level
- HLP $1.10
- SRTS $3.24
- Average True Range (ATR)
- HLP 0.09
- SRTS 0.09
- MACD
- HLP 0.02
- SRTS 0.04
- Stochastic Oscillator
- HLP 79.03
- SRTS 34.11
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.